Sage Journals: Discover world-class research

Retricted access

Research article

First published 2025-10

Medication-related jaw osteonecrosis in metastatic RCC treated with VEGFR-TKIs ± IO and bone agents: A real-world analysis

Marco Stellato, Ernesto Zecca, Paola Bracchi [...]

Tumori Journal

Open access

Brief report

First published 2024-06-21

Durability of Response with First-Line Combined Immune Checkpoint Inhibitor Therapy Compared to Checkpoint Inhibitor with VEGFR-TKI in Advanced Clear Cell Renal Cell Carcinoma

Jacob Zaemes, David F. McDermott, Meredith M. Regan [...]

Kidney Cancer

Open access

Review article

First published 2020

Tyrosine kinase inhibitors and immunotherapy combinations in renal cell carcinoma

Elie Rassy, Ronan Flippot, Laurence Albiges

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2011

Pharmacotherapy Options in Advanced Renal Cell Carcinoma: What Role for Pazopanib?

Michael R. Harrison

Clinical Medicine Insights: Oncology

Retricted access

Review article

First published 2013-02

Tyrosine Kinase Inhibitor–Induced Thyroid Disorders: A Review and Hypothesis

Noriko Makita, Taroh Iiri

Thyroid®

Free access

Research article

First published 2013-10

The prospects of pazopanib in advanced renal cell carcinoma

Shilpa Gupta, Philippe E. Spiess

Therapeutic Advances in Urology

Open access

Review article

First published 2022-12-29

Activity of Immunotherapy Regimens on Primary Renal Tumours: A Systematic Review

James O. Jones, William H. J. Ince, Sarah J. Welsh [...]

Kidney Cancer

Retricted access

Research article

First published 2018-4

Effect of treatment dose reductions in the setting of hand-foot syndrome on survival outcomes in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor receptor inhibitors

Erin B Bailey, Joseph Merriman, Benjamin Maughan [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2010

Pazopanib for the Treatment of Patients with Advanced Renal Cell Carcinoma

Joshua M. Lang, Michael R. Harrison

Clinical Medicine Insights: Oncology

Retricted access

Research article

First published 2021-6

Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study

Kelsey H Natsuhara, Li Zhang, Christopher A Carlos [...]

Journal of Onco-Nephrology

Search results